ENSC
Price:
$0.2713
Market Cap:
$2.52M
Ensysce Biosciences, Inc. is a clinical-stage pharmaceutical firm dedicated to developing novel prescription drugs for the treatment of severe pain in the United States, with a specific focus on preventing opioid addiction, misuse, abuse, and overdose. The company leverages two primary technological frameworks: the Trypsin Activated Abuse Protection (TAAP) platform, which creates opioid prodrugs designed to resist abuse, and the Multi-Pill Abuse Resistance (MPAR) platform, engineered to offer protection against overdose through its advanced opioid prodrug technology. Ensysce's pipeline features several key candidates, including PF614, an oxycodone prodrug developed using the TAAP platform, c...[Read more]
Industry
Biotechnology
IPO Date
2018-03-14
Stock Exchange
NASDAQ
Ticker
ENSC
According to Ensysce Biosciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.09. This represents a change of -79.20% compared to the average of -0.43 of the last 4 quarters.
The mean historical PE Ratio of Ensysce Biosciences, Inc. over the last ten years is -726227.33. The current -0.09 PE Ratio has changed -100.00% with respect to the historical average. Over the past ten years (40 quarters), ENSC's PE Ratio was at its highest in in the March 2018 quarter at 127.25K. The PE Ratio was at its lowest in in the September 2017 quarter at -10743750.00.
Average
-726227.33
Median
-1.78
Minimum
-6611538.46
Maximum
156.30K
Discovering the peaks and valleys of Ensysce Biosciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 250.17%
Maximum Annual PE Ratio = 156.30K
Minimum Annual Increase = -197.27%
Minimum Annual PE Ratio = -6611538.46
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -0.23 | -87.02% |
| 2024 | -1.78 | -47.46% |
| 2023 | -3.39 | 250.17% |
| 2022 | -0.97 | -97.96% |
| 2021 | -47.57 | -100.06% |
| 2020 | 79.94K | -48.86% |
| 2019 | 156.30K | -197.27% |
| 2018 | -160690.91 | -97.57% |
The current PE Ratio of Ensysce Biosciences, Inc. (ENSC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1.80
5-year avg
-10.79
10-year avg
-726227.33
Ensysce Biosciences, Inc.’s PE Ratio is greater than Soligenix, Inc. (-0.20), less than Titan Pharmaceuticals, Inc. (13.82), less than Oragenics, Inc. (-0.09), greater than KALA BIO, Inc. (-1.25), greater than Xenetic Biosciences, Inc. (-2.28), greater than AIM ImmunoTech Inc. (-0.21), greater than VYNE Therapeutics Inc. (-1.31), greater than Qualigen Therapeutics, Inc. (-0.14), greater than Kazia Therapeutics Limited (-1.91), greater than Can-Fite BioPharma Ltd. (-686.14),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.20 | $4.12M | |
| 13.82 | $3.11M | |
| -0.09 | $2.48M | |
| -1.25 | $79.17M | |
| -2.28 | $5.29M | |
| -0.21 | $1.29M | |
| -1.31 | $10.59M | |
| -0.14 | $5.43M | |
| -1.91 | $22.45M | |
| -686.14 | $1.60M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ensysce Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Ensysce Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Ensysce Biosciences, Inc.'s PE Ratio?
How is the PE Ratio calculated for Ensysce Biosciences, Inc. (ENSC)?
What is the highest PE Ratio for Ensysce Biosciences, Inc. (ENSC)?
What is the 3-year average PE Ratio for Ensysce Biosciences, Inc. (ENSC)?
What is the 5-year average PE Ratio for Ensysce Biosciences, Inc. (ENSC)?
How does the current PE Ratio for Ensysce Biosciences, Inc. (ENSC) compare to its historical average?